Literature DB >> 6120372

Intravenous immunoglobulin in antibody deficiency syndromes.

L A Hanson, J Björkander, C Wadsworth, B Bake.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6120372     DOI： 10.1016/s0140-6736(82)91421-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Inhibition of human coronavirus NL63 infection at early stages of the replication cycle.

Authors:  Krzysztof Pyrc; Berend Jan Bosch; Ben Berkhout; Maarten F Jebbink; Ronald Dijkman; Peter Rottier; Lia van der Hoek
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  Some side effects of intravenous 7S-immunoglobulins are due to immune complexes and can be prevented by 5S-immunoglobulin given prior to 7S treatment.

Authors:  G P Tilz
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.